Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Vahid Karpisheh

17 ta ish

Tabriz University of Medical Sciences

AkademScholarda batafsil koʻrsatkichlar

  1. The role of regulatory T cells in the pathogenesis and treatment of prostate cancer

    Vahid Karpisheh, Seyedeh Mahboubeh Mousavi, Parinaz Naghavi Sheykholeslami +6

    Sharh maqola20218 iqtibos
    ABI

  2. Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells

    Mehrdad Fathi, Simin Bahmanpour, Asal Barshidi +12

    Maqola20216 iqtibos
    ABI

  3. Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer

    Vahid Karpisheh, Afshin Nikkhoo, Mohammad Hojjat‐Farsangi +7

    Sharh maqola20196 iqtibos
    ABI

  4. EP4 receptor as a novel promising therapeutic target in colon cancer

    Vahid Karpisheh, Navneet Joshi, Angelina Olegovna Zekiy +5

    Sharh maqola20206 iqtibos
    ABI

  5. The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha

    Mohammad Reza Sadeghi, Asma Moslehi, Hadiseh Kheiry +11

    Maqola20246 iqtibos
    ABI

  6. Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide

    Atefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer +13

    MaqolaOchiq kirish20235 iqtibos
    ABI

  7. The role of Th17 cells in the pathogenesis and treatment of breast cancer

    Vahid Karpisheh, Majid Ahmadi, Kazem Abbaszadeh‐Goudarzi +5

    Sharh maqola20225 iqtibos
    ABI

  8. The molecular biology and therapeutic potential of Nrf2 in leukemia

    Atefeh Khodakarami, Sara Adibfar, Vahid Karpisheh +6

    Sharh maqola20225 iqtibos
    ABI

  9. Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticles

    Abbas Ali Hosseinpour Feizi, Sajjad Vakili‐Samiani, Vahid Karpisheh +11

    MaqolaOchiq kirish20224 iqtibos
    ABI

  10. RETRACTED: Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression

    Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli +11

    Maqola20214 iqtibos
    ABI

  11. Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art

    Zahra Hatami, Zahra Sadat Hashemi, Mohamad Eftekhary +4

    Sharh maqola20234 iqtibos
    ABI

  12. Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1

    Shiva Abolhasani, Armin Mahmoud Salehi Khesht, Atefeh Khodakarami +13

    Maqola20254 iqtibos
    ABI

  13. Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression

    Farnaz Hajizadeh, Sadaf Moghadaszadeh Ardebili, Mahdi Baghi Moornani +12

    Maqola20204 iqtibos
    ABI

  14. The role of <scp>SF3B1</scp> and <scp>NOTCH1</scp> in the pathogenesis of leukemia

    Shiva Abolhasani, Seyyed Sina Hejazian, Vahid Karpisheh +5

    Sharh maqola20224 iqtibos
    ABI

  15. T‐cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer

    Mehrdad Fathi, Inna Pustokhina, Sergey V. Kuznetsov +5

    Sharh maqola20213 iqtibos
    ABI

  16. Pan Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer

    Sepideh Izadi, Mohammad Hojjat Farsang, Vahid Karpisheh +1

    Maqola20233 iqtibos
    ABI

  17. Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses

    Sara Adibfar, Ali Masjedi, Atefeh Nazer +9

    Maqola20223 iqtibos
    ABI